FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 5, 2000
MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-11394 95-3863205
(Commission File Number) (IRS Employer Identification No.)
402 West County Road D
St. Paul, Minnesota 55112
(Address of principal executive offices) (Zip Code)
(651) 636-7466
(Registrant's telephone number, including area code)
<PAGE>
Item 9. Regulation F-D Disclosure
On December 5, 2000, the Company announced that it will take a $500,000
charge against earnings in the quarter ended December 31, 2000 as described in
the press release attached at Exhibit 99.1.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDTOX Scientific, Inc.
Date: December 5, 2000 By: /s/ Richard J. Braun
--------------------------
Name: Richard J. Braun
Title: Chief Executive Officer
